MAUNA KEA TECHNOLOGIES (EPA:MKEA) Mauna Kea Technologies announces the full exercise of the over-allotment option, increasing the size of its initial public offering to approximately €56.5 million

Transparency directive : regulatory news

11/07/2011 19:54

Paris, July 11 2011

Mauna Kea Technologies announces the full exercise of the over-allotment
option, increasing the size of its initial public offering to approximately
EUR56.5 million

Mauna Kea Technologies announced today in relation to its initial public
offering that the Lead Manager and Bookrunner, Société Générale, on behalf
of the Underwriters, has exercised in full the over-allotment option, resulting
in the purchase of 566,901 additional new shares at the offering price of EUR13
per share.

As a result, the total number of Mauna Kea Technologies shares offered to the
market in connection with its IPO amounts to 4,346,243 new shares, or
approximately 32.73% of Mauna Kea Technologies' share capital and 20.23% of its
voting rights.

The total size of Mauna Kea Technologies' initial public offering, including
the Public Offering and the Global Placement, increased to EUR56,501,159.

In addition, Société Générale, in its capacity as stabilising agent, has
informed Mauna Kea Technologies that no stabilisation was carried out during
the stabilisation period, which started on July 5th, 2011 (after the issue of
Mauna Kea Technologies' press release announcing the results and the price of
the offering) and ended today.

Public information

The legal and financial documents to be made available to shareholders may be
consulted at the Company's head office, 9, rue d'Enghien, 75010 Paris, France.

The French market authority (Autorité des marchés financiers (the "AMF"))
granted visa n° 11-236 on 20 June 2011 to the prospectus relating to Mauna Kea
Technologies' initial public offering, comprising a document de base
registered on 6 June 2011 under number I.11-035 and a note d'opération
including the prospectus summary.

Copies of the prospectus are available free of charge at the head office of
Mauna Kea Technologies, 9, rue d'Enghien, 75010 Paris, France and from Lead
Manager and Bookrunner and the co-Lead Managers. The prospectus can also be
consulted on the Mauna Kea Technologies website (www.maunakeatech.com) and on
the AMF website (www.amffrance.org).

Mauna Kea Technologies draws investors' attention to Section 4 "Risk factors"
of the document de base registered with the AMF, as well as Section 2 "Risk
factors relating to the Offering" of the note d'opération. The occurrence of
all or any of these risks is likely to have a negative effect on the Company's
activities, results, financial situation and outlook.

About Mauna Kea Technologies:
Mauna Kea Technologies is a global medical imaging company and a leader in
endomicroscopic innovation. The company researches, develops and markets
innovative tools to visualize and detect abnormalities in the gastro-intestinal
and pulmonary tracts. Its flagship product, Cellvizio(r), a probe-based
Confocal Laser Endomicroscopy (pCLE) system, provides physicians and
researchers high resolution cellular views of tissue inside the body. Large,
international, multi-center clinical trials have demonstrated Cellvizio's
ability to help physicians more accurately detect early forms of disease and
make treatment decisions immediately. Designed to improve patient outcomes and
reduce costs within a hospital, Cellvizio can be used with almost any
endoscope. Cellvizio has 510(k) clearance from the U.S. Food and Drug
Administration and the European CE-Mark for use in the GI and pulmonary tracts.

For more information about Mauna Kea Technologies, visit the website
www.maunakeatech.com

Eric Cohen                      Alize RP
Vice-President Finance          Relations presse
Mauna Kea Technologies          Caroline Carmagnol / Anne-Sophie Cosquéric
Tel: +33 (0) 1 70 08 09 70      Tél. : +33(0)142 68 86 43
investor-vpf@maunakeatech.com   caroline@alizerp.com / anne-sophie@alizerp.com

Disclaimer

This press release and the information contained herein do not constitute an
offer to subscribe, or the solicitation of an offer to subscribe for Mauna Kea
Technologies shares in any country. The distribution of this press release in
certain countries may be subject to specific regulations. The persons in
possession of this press release must inquire about any local restrictions and
comply with these restrictions.

In particular:

This press release does not constitute an offer to subscribe or the
solicitation of an offer subscribe for securities in the United States. The
shares or any other securities of Mauna Kea Technologies may not be offered or
sold in the United States unless they are registered under the U.S. Securities
Act of 1933, as amended (the "U.S. Securities Act"), or exempt from
registration. The shares of Mauna Kea Technologies have not been and will not
be registered under the U.S. Securities Act and Mauna Kea Technologies does
not intend to make any public offer of its shares in the United States.

This press release is solely an advertisement and does not constitute a
prospectus within the meaning of Directive 2003/71/EC of the European
Parliament and the Council of November 4th, 2003, as amended, to the extent
such Directive has been transposed in the relevant member State of the Euro
pean Economic Area (the "Prospectus Directive").

With respect to the member States of the Euro pean Economic Area which have
implemented the Prospectus Directive, no action has been undertaken or will be
undertaken to make an offer to the public of the securities requiring a
publication by Mauna Kea Technologies of a prospectus in any member State,
other than France. As a result, the shares of Mauna Kea Technologies may not be
offered or will not be offered in any member State other than France, except,
pursuant to the exemptions described in article 3(2) of the Prospectus
Directive, if they have been transposed by the relevant member State(s) or in
any other circumstances not requiring Mauna Kea Technologies to publish a
prospectus as pro vided under article 3(2) of the Prospectus Directive and/or
regulations applicable in such member State(s).

This press release is for distribution only to persons who (i) have
professional experience in matters relating to investments falling within
Article 19(5) of the Financial Services and Markets Act 2000 (Financial
Promotion) Order 2005 (as amended, the "Financial Promotion Order"), (ii) are
persons falling within Article 49(2)(a) to (d) ("high net worth companies,
unincorporated associations etc") of the Financial Promotion Order, (iii) are
outside the United Kingdom, or (iv) are persons to whom an invitation or
inducement to engage in investment activity (within the meaning of section 21
of the Financial Services and Markets Act 2000) in connection with the issue
or sale of any securities may otherwise lawfully be communicated or caused to
be communicated (all such persons together being referred to as "relevant
persons"). This press release is directed only at relevant persons and must
not be acted on or relied on by persons who are not relevant persons. Any
investment or investment activity to which this press release relates is
available only to relevant persons and will be engaged in only with relevant
persons.

This document contains forward-looking information. No guarantee is given as to
these forecasts bein g achieved, which are subject to risks including those
described in the prospectus registered with the AMF with respect to the initial
public offering of Mauna Kea Technologies, and the development of economic
conditions, the financial markets and the markets in which Mauna Kea
Technologies operates.

  This document may not be published, distributed or disseminated, directly or
    indirectly, in the United States of America, Canada, Australia or Japan.

MAUNA KEA TECHNOLOGIES's latest news

25/04/2024 20:50

MAUNA KEA TECHNOLOGIES (EPA:MKEA) Mauna Kea Technologies announces the full exercise of the over-allotment option, increasing the size of its initial public offering to approximately €56.5 million

Transparency directive : regulatory news

MAUNA KEA TECHNOLOGIES's latest news

Other stories